Neurostimulation for Pediatric Obstructive Sleep Apnea - 26/04/24

Doi : 10.1016/j.otc.2024.02.007

Doug Chieffe, MD ^a, Christopher Hartnick, MD, MS ^a,^b,^c,^⁎
^a Otolaryngology–Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114, USA
^b Division of Pediatric Otolaryngology, Pediatric Airway, Voice, and Swallowing Center
^c Harvard Medical school, Boston, MA, USA

^∗Corresponding author. Otolaryngology–Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114.Otolaryngology–Head and Neck SurgeryMassachusetts Eye and Ear Infirmary243 Charles StreetBostonMA02114

Resumen

Up to 80% of children with Down syndrome (DS) are affected by obstructive sleep apnea (OSA), and only 16% to 30% will have resolution of their OSA with adenotonsillectomy. Hypoglossal nerve stimulation is a well-established therapy for adults with OSA and was recently approved by the Food and Drug Administration for use in children with DS and residual OSA. There is robust experience with this therapy in adults that has led to well-established care pathways. However, given the challenges inherent to caring for a complex pediatric population, these pathways are not directly transferrable to children with DS.

El texto completo de este artículo está disponible en PDF.

Keywords : Pediatric obstructive sleep apnea, Down syndrome, Upper airway stimulation